The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Open accessAbstract
Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology and pathogenesis of MetS, the role of inflammation in MetS, and summarize existing natural therapies for MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,499
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Grundy, S. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151092 · Cited by 1,563
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Bastard, J.-P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3338 · Cited by 1,104
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054
Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., Jordan, H. S., & Lau, J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.5 · Cited by 980
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 825
Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999–2010
Beltrán-Sánchez, H., Harhay, M. O., Harhay, M. M., & McElligott, S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.064 · Cited by 736
Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., & Dandona, P. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2882 · Cited by 660
Association of Hypoadiponectinemia With Impaired Vasoreactivity
Ouchi, N., Ohishi, M., Kihara, S., Funahashi, T., Nakamura, T., Nagaretani, H., Kumada, M., Ohashi, K., Okamoto, Y., Nishizawa, H., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083488.67550.b8 · Cited by 590
Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats
Rivera, L., Morón, R., Sánchez, M., Zarzuelo, A., & Galisteo, M. (2008) · Obesity · doi:10.1038/oby.2008.315 · Cited by 473
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal, B. B. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104755 · Cited by 471
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7922 · Cited by 446
Flachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P., Franssen-van Hal, N., Ruzickova, J., Sponarova, J., Drahota, Z., Vlcek, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1944-7 · Cited by 388
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371
Chen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., Shu, F., Gao, Y., Yuan, L., Zhang, Q., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.015 · Cited by 319
Méndez-del Villar, M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0082 · Cited by 246
Tsigos, C., Kyrou, I., Chala, E., Tsapogas, P., Stavridis, J. C., Raptis, S. A., & Katsilambros, N. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90277-9 · Cited by 233
Ziegenfuss, T. N., Hofheins, J. E., Mendel, R. W., Landis, J., & Anderson, R. A. (2006) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-3-2-45 · Cited by 227
Lewis, G. F., & Steiner, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.390 · Cited by 226
Xu, J., Fu, Y., & Chen, A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00474.2002 · Cited by 221
Inflammation and Atherosclerosis—Revisited
Pant, S., Deshmukh, A., GuruMurthy, G. S., Pothineni, N. V., Watts, T. E., Romeo, F., & Mehta, J. L. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413504994 · Cited by 204
Self-citationPfeuffer, M., Auinger, A., Bley, U., Kraus-Stojanowic, I., Laue, C., Winkler, P., Rüfer, C. E., Frank, J., Bösch-Saadatmandi, C., Rimbach, G., et al. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.08.010 · Cited by 181
Adverse endothelial function and the insulin resistance syndrome
Tooke, J. E., & Hannemann, M. M. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00671.x · Cited by 178
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., & Kahn, R. A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000112379.88385.67 · Cited by 175
Song, M.-Y., Kim, E.-K., Moon, W.-S., Park, J.-W., Kim, H.-J., So, H.-S., Park, R., Kwon, K.-B., & Park, B.-H. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.007 · Cited by 169
Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats
Padiya, R., Khatua, T. N., Bagul, P. K., Kuncha, M., & Banerjee, S. K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-53 · Cited by 164
Obesity-related hypertension: possible pathophysiological mechanisms
Vaněčková, I., Maletínská, L., Behuliak, M., Nagelová, V., Zicha, J., & Kuneš, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0368 · Cited by 161
Cao, H., Graves, D. J., & Anderson, R. A. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.03.023 · Cited by 124
Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Pérez-Rubio, K. G., González-Ortiz, M., Martínez-Abundis, E., Robles-Cervantes, J. A., & Espinel-Bermúdez, M. C. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0183 · Cited by 113
The impact of garlic on lipid parameters: a systematic review and meta-analysis
Reinhart, K. M., Talati, R., White, C. M., & Coleman, C. I. (2009) · Nutrition Research Reviews · doi:10.1017/s0954422409350003 · Cited by 113
Bhat, M., Kothiwale, S. K., Tirmale, A. R., Bhargava, S., & Joshi, B. N. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep033 · Cited by 104
Suppression of Transcription Factor Egr-1 by Curcumin
Pendurthi, U. R., & Rao, L. V. M. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(99)00148-6 · Cited by 91
MILLER, J. M., Kaylor, M. B., Johannsson, M. B., Bay, C. R., & Churilla, J. R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0055 · Cited by 90
Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., Xu, L., & Li, M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/363845 · Cited by 85
Wu, L., & Juurlink, B. H. J. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00016 · Cited by 75
Gómez-Arbeláez, D., Lahera, V., Oubiña, P., Valero‐Muñoz, M., Heras, N. D. L., Rodríguez, Y. A., Garcia, R. G., Camacho, P. A., & López-Jaramillo, P. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/285795 · Cited by 73
Eicosapentaenoic acid, but not oleic acid, stimulates β‐oxidation in adipocytes
Guo, W., Xie, W., Lei, T., & Hamilton, J. A. (2005) · Lipids · doi:10.1007/s11745-005-1443-8 · Cited by 72
Quercetin Impacts Expression of Metabolism- and Obesity-Associated Genes in SGBS Adipocytes
Leiherer, A., Stoemmer, K., Muendlein, A., Saely, C. H., Kinz, E., Brandtner, E. M., Fraunberger, P., & Drexel, H. (2016) · Nutrients · doi:10.3390/nu8050282 · Cited by 66
Gobal, F. A., Deshmukh, A. J., Shah, S. V., & Mehta, J. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.027 · Cited by 56
Self-citationDai, Y., Mercanti, F., Dai, D., Wang, X., Ding, Z., Pothineni, N. V. K., & Mehta, J. L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.035 · Cited by 54
Self-citationRegulation of inflammatory and lipid metabolism genes by eicosapentaenoic acid-rich oil
Gillies, P. J., Bhatia, S. K., Belcher, L. A., Hannon, D. B., Thompson, J. T., & Heuvel, J. P. V. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022657 · Cited by 54
Mollace, V., Ragusa, S., Sacco, I., Muscoli, C., Sculco, F., Visalli, V., Palma, E., Muscoli, S., Mondello, L., Dugo, P., et al. (2008) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248407313821 · Cited by 53
Metabolic Effects of Sulforaphane Oral Treatment in Streptozotocin-Diabetic Rats
de Souza, C. G., Sattler, J. A., de Assis, A. M., Rech, A., Perry, M. L. S., & Souza, D. O. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0016 · Cited by 47
Resveratrol Use in Metabolic Syndrome
Bremer, A. A. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.1505 · Cited by 25
Research works printed but not linked: 3
- Grundy SM, 2004, Arterioscler Thromb Vasc Biol, 24, e19
- Fried SK, 1998, J Clin Endocrinol Metab, 83, 847
- Bastard JP, 2000, J Clin Endocrinol Metab, 85, 3338
Cited by
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“The presence of metabolic syndrome at presentation or during treatment might require modification of the glucocorticoid regimen and supplemental therapies and lifestyle adjustments (exercise, weight reduction).(311)”
BackgroundGlobal Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
Polyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 717
Metadata
- Authors
- Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L.
- Venue
- Therapeutic Advances in Cardiovascular Disease
- Publisher
- SAGE Publications
- Published
- 2017-06-22
- Volume
- 11
- Issue
- 8
- Pages
- 215-225
- ISSN
- 1753-9447 (ISSN-L)
- 1753-9455
- OpenAlex
- W2707444060
- Cited by
- 1,097
- References
- 56
- FWCI
- 28.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.